WIB22: Suma Kr­ish­nan co-found­ed a com­pa­ny to de­vel­op a treat­ment for ‘the worst dis­ease you’ve nev­er heard of’

This pro­file is part of End­points News’ 2022 spe­cial re­port about Women in Bio­phar­ma R&D. You can read the full re­port here.

Af­ter spend­ing time with pa­tients who were di­ag­nosed with what some call “the worst dis­ease you’ve nev­er heard of,” Suma Kr­ish­nan ded­i­cat­ed her­self to find­ing a treat­ment.

Kr­ish­nan, who is the co-founder and chief op­er­at­ing of­fi­cer of Krys­tal Biotech, spear­head­ed a gene ther­a­py gel that showed promise in a late-stage clin­i­cal tri­al for dy­s­troph­ic epi­der­mol­y­sis bul­losa. The FDA is re­view­ing whether to ap­prove the ther­a­py and will de­cide by Feb­ru­ary.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER